Amyloidogenic properties of the prion protein fragment PrP(185-208): Comparison with Alzheimer's peptide Aβ(1-28), influence of heparin and cell toxicity

Biochemical and Biophysical Research Communications

Volumn 368, Issue 2, 2008, Pages 238-242

  Cortijo Arellano, Marta ^a   Ponce, Jovita ^b   Durany, Núria ^b   Cladera, Josep ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

Alzheimer; Amyloid; Fluorescence; Infrared; Peptide; Prion

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-28]; HEPARIN; HISTIDINE; PRION PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; COMPARATIVE STUDY; CYTOTOXICITY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE;

AMYLOID; AMYLOID BETA-PROTEIN; APOPTOSIS; CELL SURVIVAL; HEPARIN; HISTIDINE; HUMANS; NEUROBLASTOMA; PEPTIDE FRAGMENTS; PRPC PROTEINS;

EID: 39549106489     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.049     Document Type: Article

References (15)

1. Booth D.R., Sunde M., Bellotti V., Robinson C.V., Hutchinson W.L., Fraser P.E., Hawkins P.N., Dobson C.M., Radford S.E., Blake C.C., and Pepys M.B. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385 (1997) 787-793
2. Diaz-Nido J., Wandosell F., and Avila J. Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases. Peptides 23 (2002) 1323-1332
3. McLaurin J., and Fraser P.E. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions. Eur. J. Biochem. 267 (2000) 6353-6361
4. McLaurin J., Franklin T., Zhang X., Deng J., and Fraser P.E. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. Eur. J. Biochem. 266 (1999) 1101-1110
5. Castillo G.M., Ngo C., Cummings J., Wight T.N., and Snow A.D. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J. Neurochem. 69 (1997) 2452-2465
6. Snow A.D., Kinsella M.G., Parks E., Sekiguchi R.T., Miller J.D., Kimata K., and Wight T.N. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Arch. Biochem. Biophys. 320 (1995) 84-95
7. Priola S.A., and Caughey B. Inhibition of scrapie-associated Prp accumulation-probing the role of glycosaminoglycans in amyloidogenesis. Mol. Neurobiol. 8 (1994) 113-120
8. Ledesma M.D., Perez M., Colaco C., and Avila J. Tau glycation is involved in aggregation of the protein but not in the formation of filaments. Cell. Mol. Biol. (Noisy-le-grand) 44 (1998) 1111-1116
9. Caughey B. Scrapie-associated Prp accumulation and its prevention-insights from cell-culture. Brit. Med. Bull. 49 (1993) 860-872
10. Pollack S.J., Sadler I.I., Hawtin S.R., Tailor V.J., and Shearman M.S. Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Neurosci. Lett. 184 (1995) 113-116
11. Mahfoud R., Garmy N., Maresca M., Yahi N., Puigserver A., and Fantini J. Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J. Biol. Chem. 277 (2002) 11292-11296
12. Ma K., Clancy E.L., Zhang Y., Ray D.G., Wollenberg K., and Zagorski M.G. Residue-specific pKa measurements of the β -peptide and mechanism of pH-induced amyloid formation. J. Am. Chem. Soc. 121 (1999) 8698-8706
13. Byler D.M., and Susi H. Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers 25 (1986) 469-487
14. Klajnert B., Cortijo-Arellano M., Bryszewska M., and Cladera J. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases. Biochem. Biophys. Res. Commun. 339 (2006) 577-582
15. Klajnert B., Cortijo-Arellano M., Cladera J., and Bryszewska M. Influence of dendrimer's structure on its activity against amyloid fibril formation. Biochem. Biophys. Res. Commun. 345 (2006) 21-28